Steri-Pharma buys underperformer; Watch Tamiflu dosing;

> Sterile antibiotic maker Steri-Pharma has bought and will continue operating a cephalosporin manufacturing plant from Hanford Pharmaceuticals, which said the plant was underperforming. Article

> The Food and Drug Administration is asking doctors and pharmacists to look for dosing errors with oral Tamiflu. Article

> Drug developer and CMO Patheon has opened a pharmaceutical development services manufacturing site for investigational products within its existing manufacturing facility in Ferentino, Italy. Release

> Nycomed says it will spend about $100 million on a plant in Yaroslavl, Russia, several hundred kilometers from Moscow, to manufacture active pharmaceutical ingredients and finished dosage forms for Russia and surrounding markets. Article

> American Airlines Cargo Division (AA Cargo) has begun offering an ExpediteTC express temperature-controlled service to customers worldwide, following a trial in the early summer between ten US and international cities. Item

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.